Genetic susceptibilify of lung cancer and environmental carcinogensis

Chinese Journal of Lung Cancer

Volumn 6, Issue 6, 2003, Pages 430-433

  Zhu, Wen ^a   Zhou, Qinghua ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; CYTOCHROME P450 2A6; CYTOCHROME P450 2E1; CYTOCHROME P450 3A4; DNA; PROTEIN KINASE B;

CARCINOGENESIS; CONFERENCE PAPER; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; GENETIC SUSCEPTIBILITY; LUNG CANCER; WORLD HEALTH ORGANIZATION;

EID: 0346733190     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (33)

1. Jemal A, Murray T, Samuels A, et al. Cancer statistics, 2003. CA Cancer J Clin, 2003 53(1): 5-26.
2. Parkin DM, Bray F, Ferlay J, et al. Estimating the world cancer burden: Globocan 2000. Int J Cancer, 2001, 94(2): 153-156.
3. Theodore WM. Genetic testing for lung cancer. JGIM, 2002, 17: 946-951.
4. Shields PG. Molecular epidemiology of smoking and lung cancer. Oncogene, 2002, 21(45): 6870-6876.
5. Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst. 1999, 91(14): 1194-210.
6. Hoffmann D, Hoffmann I. The changing cigarette, 1950-1995. J Toxicol Environ Health, 1997, 50(4): 307-364.
7. Lodovici M, Akpan V, Giovannini L, et al. Benzo[a]pyrene diolepoxide DNA adducts and levels of polycyclic aromatic hydrocarbons in autopric samples from human lungs. Chem Biol Interact. 1998, 116(3): 199-212.
8. Kim JH, Stansbury KH, Walker NJ, et al. Metabolism of benzo [a] pyrene and benzo [a] pyrene-7, 8-diol by human cytochrome P450 1B1. Carcinogenesis, 1998, 19(10): 1847-1853.
9. Klein-Szanto AJ, Iizasa T, Momiki S, et al. A tobacco-specific N-nitrosamine or cigarette smoke condensate causes neoplastic transformation of xenotransplanted human bronchial epithelial cells. Proc Natl Acad Sci U S A, 1992, 89(15): 6693-6697.
10. Kamataki T, Fujita K, Nakayama K, et al. Role of human cytochrome P450 (CYP) in the metabolic activation of nitrosamine derivatives: application of genetically engineered Salmonella expressing human CYP. Drug Metab Rev, 2002, 34(3): 667-676.
11. Schoket B, Phillips DH, Kostic S, et al. Smoking-associated bulky DNA adducts in bronchial tissue related to CYP1A1 Msp1 and GSTM1 genotypes in lung patients. Carcinogenesis, 1998, 19(5): 841-846.
12. Tang D, Phillips DH, Stampfer M, et al. Association between carcinogen-DNA adducts in white blood cells and lung cancer risk in the physicians health study. Cancer Res, 2001, 61(18): 6708-6712.
13. Tang D, Phillips DH, Stampfer M, et al. Association between carcinogen-DNA adducts in white blood cells and lung cancer risk in the physicians health study. Cancer Res, 2001, 61(18): 6708-6712.
14. Denissenko MF, Pao A, Tang M, et al. Preferential formation of benzo [a] pyrene adducts at lung cancer mutational hotspots in P53. Science, 1996, 274(5286): 430-432.
15. Hartmann A, Blaszyk H, Kovach JS, et al. The molecular epidemiology of p53 gene mutations in human breast cancer. Trends Genet, 1997, 13(1): 27-33.
16. Awuti Y, Nakamura H, Saji H, et al. Association between the mRAN expression of cytochrome P450 enzymes in peripheral blood mononuclear cells and the risk of lung cancer. Lung Cancer, 2003, 41(Suppl 2): S486.
17. Lam DCL, Wong MP, Lam WK, et al. Quantitative comparison of expression of nicotinic acetylcholine receptor (nAChR) subunits between non-small cell lung cancers arising in life-time never-smokers and smokers in Chinese patients. Lung Cancer, 2003, 41(Suppl 2): S305.
18. West KA, Linnoila IR, Brognard J, et al. Tobacco carcinogen-in-duced cellular transformation increase Akt activation in vitro and in vivo. Lung Cancer, 2003, 41(Suppl 2): S16.
19. Cheng SJ, Gao YN, Zhang DC. Molecular and cytogenetic alterations in Chinese non-small cell lung cancer. Lung Cancer, 2003, 41(Suppl 2): S16.
20. Zang EA, Wynder EL. Differences in lung cancer risk between men and women: examination of the evidence. J Natl Cancer Inst, 1996, 88(3-4): 183-192.
21. Kaiser U, Hofmann J, Schilli M, et al. Steroid-hormone receptors in cell lines and tumor biopsies of human lung cancer. Int J Cancer, 1996, 67(3): 357-364.
22. Gao YT, Blot WJ, Zheng W, et al. Lung cancer among Chinese women. Int J Cancer, 1987, 40(5): 604-609.
23. Bennett WP, Alavanja MC, Blomeke B, et al. Environmental tobacco smoke, genetic susceptibility, and risk of lung cancer in never-smoking women. J Natl Cancer Inst, 1999, 91(23): 2009-2014.
24. Ryberg D, Hewer A, Phillips DH, et al. Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients. Cancer Res, 1994, 54(22): 5801-5803.
25. Oscarson M. Genetic polymorphisms in the cytochrome P450 2A6 (CYP2A6) gene: implications for interindividual differences in nicotine metabolism. Drug Metab Dispos, 2001, 29(2): 91-95.
26. Thun MJ, Henley SJ, Calle EE. Tobacco use and cancer: an epidemiologic perspective for geneticists. Oncogene, 2002, 21(48): 7307-7325.
27. Benhamou S, Lee WJ, Alexandrie AK, et al. Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk. Carcinogenesis, 2002, 23 (8): 1343-1350.
28. Sgambato A, Campisi B, Zupa A, et al. Glutarhione S-transferase (GST) polymorphisms as risk factors for cancer in a highly homogeneous population from southern Italy. Anticancer Res, 2002, 22 (6B): 3647-3652.
29. Rendic S, Di Carlo FJ. Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, induces and inhibitors. Drug Metab Rev, 1997, 29(1-2): 413-580.
30. Gsur A, Haidinger G, Hollaus P, et al. Genetic polymorphisms of CYP1A1 and GSTM1 and lung cancer risk. Anticancer Res. 2001, 21(3C): 2237-2242.
31. Gao Y, Zhang Q. Polymorphisms of the GSTM1 and CYP2D6 genes associated with susceptibility to lung cancer in Chinese. Mutat Res, 1999, 444(2): 441-449.
32. Zhang SC, Gu YF. Relationship between genetic polymorphism of metabolizing enzymes and tobacco-related lung cancer. Lung Cancer, 2003, 41C(Suppl 2): S323.
33. Rudiger HW, Schwartz U, Serrand E, et al. Reduced 06-methyl-guanine repair in fibroblast cultures from patients with lung cancer. Cancer Res, 1989, 49(20): 5623-5626.